Leading drug makers fared worse performances

The country’s top-tier companies have struggled to find their feet during the nine months of the year, after a government-mandated price cut came into effect in April.

According to data released by Yakup.com, a pharmaceutical information provider, operating profits of industry bellwether Dong-A Pharm amounted to 61.4 billion won during the January-September period, down 4.4 percent from a ye...